Epizyme EPZM

$ 1.48 0.0%

Quarterly report 2022-Q2
added 08-09-2022

Epizyme Balance Sheet 2011-2024 | EPZM

Annual Balance Sheet Epizyme

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	122 M	52.1 M	125 M	-86.6 M	-227 M	-77.2 M	-207 M	-190 M	-124 M	-98 M	-33.3 M
Long Term Debt	216 M	216 M	23.3 M	-	-	-	-	-	-	-	-
Long Term Debt Current	4.15 M	4.66 M	3.04 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	245 M	59.1 M	4.66 M	29.3 M	29.1 M	29.9 M	21.9 M	24.1 M	119 M	76.7 M
Total Current Liabilities	45.2 M	43.4 M	34.4 M	37.8 M	24.7 M	21.6 M	18.4 M	17 M	34.6 M	-	-
Total Liabilities	-	289 M	93.5 M	42.5 M	54 M	50.7 M	48.4 M	38.9 M	58.7 M	155 M	88 M
Deferred Revenue	-	-	-	13.3 M	-	-	1.9 M	1.7 M	23.2 M	28.2 M	7.1 M
Retained Earnings	-1.24 B	-989 M	-757 M	-587 M	-488 M	-354 M	-243 M	-111 M	-56.1 M	-52.6 M	-51.9 M
Total Assets	289 M	474 M	425 M	276 M	289 M	252 M	218 M	199 M	163 M	104 M	37.4 M
Cash and Cash Equivalents	98.3 M	168 M	139 M	86.7 M	227 M	77.9 M	208 M	190 M	124 M	98 M	33.3 M
Book Value	289 M	185 M	331 M	233 M	235 M	202 M	170 M	160 M	104 M	-51.1 M	-50.6 M
Total Shareholders Equity	-20.7 M	185 M	331 M	233 M	235 M	202 M	170 M	160 M	104 M	-51.1 M	-50.6 M

All numbers in USD currency

Quarterly Balance Sheet Epizyme

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	217 M	217 M	216 M	216 M	216 M	216 M	216 M	216 M	216 M	216 M	23.3 M	23.3 M	23.3 M	23.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	5 M	-	-	-	-	-	1.79 M	6.26 M	5.41 M	13.3 M	13.3 M	13.3 M	13.3 M	-	-	-	-	-	478 K	956 K	1.43 M	1.9 M	1.9 M	1.9 M	1.9 M	1.7 M	1.7 M	1.7 M	1.7 M	23.2 M	23.2 M	23.2 M	23.2 M	28.2 M	28.2 M	28.2 M	-	-	-	-	-
Retained Earnings	-	-	-1.33 B	-1.3 B	-1.24 B	-1.19 B	-1.12 B	-1.06 B	-989 M	-989 M	-989 M	-989 M	-757 M	-757 M	-757 M	-757 M	-587 M	-587 M	-587 M	-587 M	-488 M	-488 M	-488 M	-488 M	-354 M	-354 M	-354 M	-354 M	-243 M	-243 M	-243 M	-243 M	-111 M	-111 M	-111 M	-111 M	-56.1 M	-56.1 M	-56.1 M	-56.1 M	-52.6 M	-52.6 M	-52.6 M	-	-	-	-	-
Total Assets	-	-	264 M	312 M	289 M	332 M	353 M	407 M	474 M	474 M	474 M	474 M	425 M	425 M	425 M	425 M	276 M	276 M	276 M	276 M	289 M	289 M	289 M	289 M	252 M	252 M	252 M	252 M	218 M	218 M	218 M	218 M	199 M	199 M	199 M	199 M	163 M	163 M	163 M	163 M	104 M	104 M	104 M	-	-	-	-	-
Cash and Cash Equivalents	-	-	71.1 M	77.4 M	98.3 M	125 M	80.2 M	73.7 M	168 M	168 M	168 M	168 M	139 M	139 M	139 M	139 M	86.7 M	86.7 M	86.7 M	86.7 M	227 M	227 M	227 M	227 M	77.9 M	77.9 M	77.9 M	77.9 M	208 M	208 M	208 M	208 M	190 M	190 M	190 M	190 M	124 M	124 M	124 M	124 M	98 M	98 M	98 M	-	33.3 M	-	-	-
Book Value	-	-	264 M	312 M	289 M	332 M	353 M	407 M	474 M	474 M	474 M	474 M	425 M	425 M	425 M	425 M	276 M	276 M	276 M	276 M	289 M	289 M	289 M	289 M	252 M	252 M	252 M	252 M	218 M	218 M	218 M	218 M	199 M	199 M	199 M	199 M	163 M	163 M	163 M	163 M	104 M	104 M	104 M	-	-	-	-	-
Total Shareholders Equity	-	-	-20.3 M	11.1 M	-20.7 M	15.4 M	67.6 M	123 M	185 M	185 M	185 M	185 M	331 M	331 M	331 M	331 M	233 M	233 M	233 M	233 M	235 M	235 M	235 M	235 M	202 M	202 M	202 M	202 M	170 M	170 M	170 M	170 M	160 M	160 M	160 M	160 M	104 M	104 M	104 M	104 M	-51.1 M	-51.1 M	-51.1 M	-	-50.6 M	-	-	-

All numbers in USD currency